NewsBenzingaDenali Therapeutics erwartet für das 4. Quartal einen Umsatz von 30,000 Mio. bis 32,000 Mio. US-Dollar gegenüber den geschätzten 22,659 Mio. US-Dollar Denali Therapeutics erwartet für das 4. Quartal einen Umsatz von 30,000 Mio. bis 32,000 Mio. US-Dollar gegenüber den geschätzten 22,659 Mio. US-Dollar Benzinga 2026.11.03 22:35 (GMT+0) Open on Benzinga Other news Motorola Solutions Hikes Quarterly Dividend From $1.21 To $1.34 Per Share These 9 Congress Members Could Have Increased Interest in Nvidia’s Q3 Earnings as 2026 Shareholders $100 Invested In Cigna Group 20 Years Ago Would Be Worth This Much Today Needham Maintains Buy on FuboTV, Lowers Price Target to $10 BTIG Reiterates Buy on Amer Sports, Maintains $42 Price Target Ahead of Palo Alto Networks Earnings, Here's What Barchart Data Says Comes Next for PANW Stock